haemoglobin designed for use as a “blood substitute.” Nature 1992; 356:258–60 10. Levy JH, Despotis GJ, Olson PJ, Weisinger A, Szlam F: Transgenically produced recombinant human ATIII enhances the antithrombotic effects of heparin in patients undergoing cardiac surgery. Blood 1997; 90(Suppl 1):298A 11. Levy JH, Goodnough LT, Grelich P, Parr G, Steward RW, Gratz I, Wahr J, Williams J, Comunale M...